These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The emerging role of microRNAs in bone remodeling and its therapeutic implications for osteoporosis. Feng Q; Zheng S; Zheng J Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29848766 [TBL] [Abstract][Full Text] [Related]
3. [Epigenetic Aspects of Osteoporosis]. Grebennikova TA; Belaya ZhE; Rozhinskaya LY; Mel'nichenko GA; Dedov II Vestn Ross Akad Med Nauk; 2015; (5):541-8. PubMed ID: 26846079 [TBL] [Abstract][Full Text] [Related]
4. The Regulatory Roles of MicroRNAs in Bone Remodeling and Perspectives as Biomarkers in Osteoporosis. Sun M; Zhou X; Chen L; Huang S; Leung V; Wu N; Pan H; Zhen W; Lu W; Peng S Biomed Res Int; 2016; 2016():1652417. PubMed ID: 27073801 [TBL] [Abstract][Full Text] [Related]
5. Systemic Activation of Activin A Signaling Causes Chronic Kidney Disease-Mineral Bone Disorder. Sugatani T Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30142896 [TBL] [Abstract][Full Text] [Related]
6. Regulation of Bone Metabolism by microRNAs. Taipaleenmäki H Curr Osteoporos Rep; 2018 Feb; 16(1):1-12. PubMed ID: 29335833 [TBL] [Abstract][Full Text] [Related]
7. RNA therapeutics targeting osteoclast-mediated excessive bone resorption. Wang Y; Grainger DW Adv Drug Deliv Rev; 2012 Sep; 64(12):1341-57. PubMed ID: 21945356 [TBL] [Abstract][Full Text] [Related]
8. Gene therapy for repair and regeneration of bone and cartilage. Grol MW; Lee BH Curr Opin Pharmacol; 2018 Jun; 40():59-66. PubMed ID: 29621661 [TBL] [Abstract][Full Text] [Related]
9. Bone health and multiple sclerosis. Dobson R; Ramagopalan S; Giovannoni G Mult Scler; 2012 Nov; 18(11):1522-8. PubMed ID: 22740489 [TBL] [Abstract][Full Text] [Related]
11. Molecular Mechanisms and Emerging Therapeutics for Osteoporosis. Noh JY; Yang Y; Jung H Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33076329 [TBL] [Abstract][Full Text] [Related]
12. Biomarkers for osteoporosis management: utility in diagnosis, fracture risk prediction and therapy monitoring. Garnero P Mol Diagn Ther; 2008; 12(3):157-70. PubMed ID: 18510379 [TBL] [Abstract][Full Text] [Related]
13. Genetic influences on bone turnover, bone density and fracture. Kelly PJ; Morrison NA; Sambrook PN; Nguyen TV; Eisman JA Eur J Endocrinol; 1995 Sep; 133(3):265-71. PubMed ID: 7581940 [No Abstract] [Full Text] [Related]
14. Protein Markers in Osteoporosis. Porcelli T; Pezzaioli L; Delbarba A; Maffezzoni F; Cappelli C; Ferlin A Protein Pept Lett; 2020; 27(12):1253-1259. PubMed ID: 32334493 [TBL] [Abstract][Full Text] [Related]
15. Gene therapy methods in bone and joint disorders. Evaluation of the adeno-associated virus vector in experimental models of articular cartilage disorders, periprosthetic osteolysis and bone healing. Ulrich-Vinther M Acta Orthop Suppl; 2007 Apr; 78(325):1-64. PubMed ID: 17427340 [TBL] [Abstract][Full Text] [Related]
16. The Potential of Probiotics as a Therapy for Osteoporosis. Collins FL; Rios-Arce ND; Schepper JD; Parameswaran N; McCabe LR Microbiol Spectr; 2017 Aug; 5(4):. PubMed ID: 28840819 [TBL] [Abstract][Full Text] [Related]
17. Assessment of bone quality, quantity, and turnover with multiple methodologies at multiple skeletal sites. Chesnut C; Majumdar S; Gardner J; Shields A; Newitt DC; Erickson E; Glott M; Kriegman A; Mindeholm L Adv Exp Med Biol; 2001; 496():95-7. PubMed ID: 11783630 [No Abstract] [Full Text] [Related]
18. RNA interference-based osteoanabolic therapy for osteoporosis by a bone-formation surface targeting delivery system. Gao Y; Xin H; Cai B; Wang L; Lv Q; Hou Y; Liu F; Dai T; Kong L Biochem Biophys Res Commun; 2022 Apr; 601():86-92. PubMed ID: 35231656 [TBL] [Abstract][Full Text] [Related]
19. The Role of Cannabinoids in Bone Metabolism: A New Perspective for Bone Disorders. Saponaro F; Ferrisi R; Gado F; Polini B; Saba A; Manera C; Chiellini G Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830256 [TBL] [Abstract][Full Text] [Related]
20. Small non-coding RNAs-based bone regulation and targeting therapeutic strategies. Yang Y; Fang S Mol Cell Endocrinol; 2017 Nov; 456():16-35. PubMed ID: 27888003 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]